Selective cytotoxicity of Aniba rosaeodora essential oil towards epidermoid cancer cells through induction of apoptosis

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 718, Issue 1-2, 2011, Pages 24-32

  Sœur, Jérémie ^a,b   Marrot, Laurent ^b   Perez, Philippe ^b   Iraqui, Ismail ^a   Kienda, Guy ^a   Dardalhon, Michèle ^a   Meunier, Jean Roch ^b   Averbeck, Dietrich ^a   Huang, Meng Er ^a  

^a CNRS UMR3348   (France)

^b International Safety Research Department   (France)

Author keywords

Apoptosis; Epidermoid carcinoma; Essential oil; Keratinocyte; Oxidative stress

Indexed keywords

ANIBA ROSAEODORA EXTRACT; ANTINEOPLASTIC AGENT; CASPASE 3; ESSENTIAL OIL; PHOSPHATIDYLSERINE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIBA ROSAEODORA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; MEDICINAL PLANT; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CELL; SQUAMOUS CELL CARCINOMA;

ANIBA ROSAEODORA;

EID: 78650176901     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.10.009     Document Type: Article

References (42)

1. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br. J. Dermatol. 2002, 146(Suppl. 61):1-6.
2. Trakatelli M., Ulrich C., del Marmol V., Euvrard S., Stockfleth E., Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br. J. Dermatol. 2007, 156(Suppl. 3):1-7.
3. Ortonne J.P. From actinic keratosis to squamous cell carcinoma. Br. J. Dermatol. 2002, 146(Suppl. 61):20-23.
4. Rodust P.M., Stockfleth E., Ulrich C., Leverkus M., Eberle J. UV-induced squamous cell carcinoma-a role for antiapoptotic signalling pathways. Br. J. Dermatol. 2009, 161(Suppl. 3):107-115.
5. Gasparro F.P. Sunscreens, skin photobiology, and skin cancer: the need for UVA protection and evaluation of efficacy. Environ. Health Perspect. 2000, 108(Suppl. 1):71-78.
6. Park E.J., Pezzuto J.M. Botanicals in cancer chemoprevention. Cancer Metastasis Rev. 2002, 21:231-255.
7. Bakkali F., Averbeck S., Averbeck D., Idaomar M. Biological effects of essential oils-a review. Food Chem. Toxicol. 2008, 46:446-475.
8. Tahraoui A., El-Hilaly J., Israili Z.H., Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province). J. Ethnopharmacol. 2007, 110:105-117.
9. Cross S.E., Russell M., Southwell I., Roberts M.S. Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro. Eur. J. Pharm. Biopharm. 2008, 69:214-222.
10. Gutierrez J., Barry-Ryan C., Bourke P. The antimicrobial efficacy of plant essential oil combinations and interactions with food ingredients. Int. J. Food Microbiol. 2008, 124:91-97.
11. Chaieb K., Zmantar T., Ksouri R., Hajlaoui H., Mahdouani K., Abdelly C., Bakhrouf A. Antioxidant properties of the essential oil of Eugenia caryophyllata and its antifungal activity against a large number of clinical Candida species. Mycoses 2007, 50:403-406.
12. Manohar V., Ingram C., Gray J., Talpur N.A., Echard B.W., Bagchi D., Preuss H.G. Antifungal activities of origanum oil against Candida albicans. Mol. Cell. Biochem. 2001, 228:111-117.
13. Mezzoug N., Elhadri A., Dallouh A., Amkiss S., Skali N.S., Abrini J., Zhiri A., Baudoux D., Diallo B., El Jaziri M., Idaomar M. Investigation of the mutagenic and antimutagenic effects of Origanum compactum essential oil and some of its constituents. Mutat. Res. 2007, 629:100-110.
14. Su M., Wu P., Li Y., Chung H.Y. Antiproliferative effects of volatile oils from Centipeda minima on human nasopharyngeal cancer CNE cells. Nat. Prod. Commun. 2010, 5:151-156.
15. Kumar A., Malik F., Bhushan S., Sethi V.K., Shahi A.K., Kaur J., Taneja S.C., Qazi G.N., Singh J. An essential oil and its major constituent isointermedeol induce apoptosis by increased expression of mitochondrial cytochrome c and apical death receptors in human leukaemia HL-60 cells. Chem. Biol. Interact. 2008, 171:332-347.
16. Verma M., Singh S.K., Bhushan S., Pal H.C., Kitchlu S., Koul M.K., Thappa R.K., Saxena A.K. Induction of mitochondrial-dependent apoptosis by an essential oil from Tanacetum gracile. Planta Med. 2008, 74:515-520.
17. Loizzo M.R., Tundis R., Menichini F., Saab A.M., Statti G.A., Menichini F. Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells. Cell Prolif. 2008, 41:1002-1012.
18. Calcabrini A., Stringaro A., Toccacieli L., Meschini S., Marra M., Colone M., Salvatore G., Mondello F., Arancia G., Molinari A. Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. J. Invest. Dermatol. 2004, 122:349-360.
19. Yan R., Yang Y., Zeng Y., Zou G. Cytotoxicity and antibacterial activity of Lindera strychnifolia essential oils and extracts. J. Ethnopharmacol. 2009, 121:451-455.
20. de Almeida R.N., Araujo D.A., Goncalves J.C., Montenegro F.C., de Sousa D.P., Leite J.R., Mattei R., Benedito M.A., de Carvalho J.G., Cruz J.S., Maia J.G. Rosewood oil induces sedation and inhibits compound action potential in rodents. J. Ethnopharmacol. 2009, 124:440-443.
21. Beric T., Nikolic B., Stanojevic J., Vukovic-Gacic B., Knezevic-Vukcevic J. Protective effect of basil (Ocimum basilicum L.) against oxidative DNA damage and mutagenesis. Food Chem. Toxicol. 2008, 46:724-732.
22. Mitic-Culafic D., Zegura B., Nikolic B., Vukovic-Gacic B., Knezevic-Vukcevic J., Filipic M. Protective effect of linalool, myrcene and eucalyptol against t-butyl hydroperoxide induced genotoxicity in bacteria and cultured human cells. Food Chem. Toxicol. 2009, 47:260-266.
23. Usta J., Kreydiyyeh S., Knio K., Barnabe P., Bou-Moughlabay Y., Dagher S. Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels. Chem. Biol. Interact. 2009, 180:39-46.
24. Park D.J., Nakamura H., Chumakov A.M., Said J.W., Miller C.W., Chen D.L., Koeffler H.P. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 1994, 9:1899-1906.
25. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell. Biol. 1988, 106:761-771.
26. He Y.Y., Pi J., Huang J.L., Diwan B.A., Waalkes M.P., Chignell C.F. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene 2006, 25:3680-3688.
27. Dijoux N., Guingand Y., Bourgeois C., Durand S., Fromageot C., Combe C., Ferret P.J. Assessment of the phototoxic hazard of some essential oils using modified 3T3 neutral red uptake assay. Toxicol. In Vitro 2006, 20:480-489.
28. Krysko D.V., Vanden Berghe T., D'Herde K., Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008, 44:205-221.
29. Galluzzi L., Zamzami N., de La Motte Rouge T., Lemaire C., Brenner C., Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis 2007, 12:803-813.
30. Brenner D., Mak T.W. Mitochondrial cell death effectors. Curr. Opin. Cell. Biol. 2009, 21:871-877.
31. Peter M.E., Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell. Death Differ. 2003, 10:26-35.
32. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell. Biol. 2008, 9:47-59.
33. Ow Y.P., Green D.R., Hao Z., Mak T.W. Cytochrome c: functions beyond respiration. Nat. Rev. Mol. Cell. Biol. 2008, 9:532-542.
34. Lovell J.F., Billen L.P., Bindner S., Shamas-Din A., Fradin C., Leber B., Andrews D.W. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax. Cell 2008, 135:1074-1084.
35. Moll U.M., Wolff S., Speidel D., Deppert W. Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell. Biol. 2005, 17:631-636.
36. Lehman T.A., Modali R., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N., Rogan E.M., et al. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 1993, 14:833-839.
37. Xia L., Chen D., Han R., Fang Q., Waxman S., Jing Y. Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells. Mol. Cancer Ther. 2005, 4:381-388.
38. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., Nunez G., Krammer P.H., Peter M.E., Debatin K.M. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997, 57:4956-4964.
39. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.
40. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995, 358:1-3.
41. Won J.S., Singh I. Sphingolipid signaling and redox regulation. Free Radic. Biol. Med. 2006, 40:1875-1888.
42. De Flora S., Izzotti A., D'Agostini F., Balansky R.M. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 2001, 22:999-1013.